C

Compass Therapeutics LLC

35 employees

Compass Therapeutics is a biopharmaceutical company that focuses on drugging the immune system to treat human diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Biologics
Therapeutics
Immuno-Oncology
Oncology
Biopharma
Drug Discovery and Development

Date founded

2014

Funding rounds raised

Total raised

$61M

from 26 investors over 26 rounds

C

Compass Therapeutics LLC raised $61M on July 1, 2020

Investors: F-Prime Capital Partners, OrbiMed Advisors, Borealis Ventures, Thiel Capital and Biomatics Capital

C

Compass Therapeutics LLC raised $49M on July 12, 2018

Investors: Ulysses Diversified Holdings, Borealis Ventures, Biomatics Capital, Thiel Capital, F-Prime Capital Partners and OrbiMed Advisors

C

Compass Therapeutics LLC raised undisclosed on July 11, 2017

Investors: Green D Ventures, Yard Ventures, OrbiMed Advisors, F-Prime Capital Partners, GV, JLABS, Ulysses Management LLC, Thiel Capital and Polaris Partners

C

Compass Therapeutics LLC raised $50M on September 21, 2016

Investors: Founders Fund, Alumni Ventures Group and 10X Capital

C

Compass Therapeutics LLC raised $16M on July 8, 2015

Investors: 10X Capital, Alumni Ventures Group and Borealis Ventures

FAQ